课题基金 / 基金详情

HETEROGENEITY AMONG HUMAN CD4+ T-CELL CLONES

HETEROGENEITY AMONG HUMAN CD4+ T-CELL CLONES
人类 CD4 T 细胞克隆的异质性
批准号:
7375185
负责人:
RICHARD Barry MOSS
金额:
$0.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

RICHARD Barry MOSS的其他基金

相似基金

相关文献

中文摘要
翻译
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。这些研究的目的是了解哮喘和过敏性疾病的免疫生物学。我们将识别和研究下调人类过敏免疫反应的机制,并确定参与保护过敏性炎症的细胞类型和分子。这些研究涉及使用MCH ii类肽四聚体和cDNA微阵列。在不久的将来,一些受试者将接受过敏原免疫治疗,并监测免疫反应的变化。在其他研究中,我们正试图识别引起过敏和哮喘的基因及其多态性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of these studies is to understand the immunobiology of asthma and allergic diseases. We will identify and examine mechanisms that down-modulate allergic immune responses in humans, and determine the cell types and molecules that participate in the protection against allergic inflammation. These studies involve using MCH class II-peptide tetramers and cDNA microarrays. In the near future, some subjects will be treated with allergen immunotherapy and the changes in immune responses will be monitored. In other studies, we are attempting to identify genes and their polymorphisms that are involved in causing allergy and asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PHASE I/II, SINGLE-CENTER, BLINDED, RANDOMIZED, CONTROLLED STUDY OF XOLAIR
  • 批准号:
    7605198
  • 项目类别:
  • 资助金额:
    $0.82万
  • 财政年份:
    2007
  • 负责人:
    RICHARD Barry MOSS
  • 依托单位:
CLINICAL TRIAL: VX-770 CFTR ACTIVITY IN CYSTIC FIBROSIS (CF) SUBJECTS WITH GENOT
  • 批准号:
    7717937
  • 项目类别:
  • 资助金额:
    $0.1万
  • 财政年份:
    2007
  • 负责人:
    RICHARD Barry MOSS
  • 依托单位:
PTC124 AS AN ORAL TREATMENT FOR NONSENSE-MUTATION-MEDIATED CYSTIC FIBROSIS
  • 批准号:
    7605255
  • 项目类别:
  • 资助金额:
    $1.4万
  • 财政年份:
    2007
  • 负责人:
    RICHARD Barry MOSS
  • 依托单位:
DIABETES THERAPY IN CF PATIENTS WITH ABNORMAL GLUCOSE TOLERANCE
  • 批准号:
    7605163
  • 项目类别:
  • 资助金额:
    $0.12万
  • 财政年份:
    2007
  • 负责人:
    RICHARD Barry MOSS
  • 依托单位:
海外基金